Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950144-98-011124
Filing Date
1998-09-30
Accepted
1998-09-30 00:00:00
Documents
10
Period of Report
1998-06-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 VIRAGEN, INC. 10-K405 6/30/98 10-K405 293060
2 COOPERATION & SUPP. AGMNT. VIRAGEN/GERM. RED CROSS EX-10.LVIII 28154
3 BUFFYCOAT SUPP. AGMNT. 7/15/98 EX-10.LIX 85837
4 AGMNT. BET. VIRAGEN & AMERICAN RED CROSS EX-10.LX 68075
5 STRATEGIC ALLIANCE AGMNT.-VIRAGEN & INFLAMMATICS EX-10.LXI 155127
6 COMMON STOCK PRIVATE EQUITY LINE SUBS. AGMNT. EX-10.LXII 303253
7 STATEMENT RE: COMPUTATION OF LOSS PER SHARE EX-11 2624
8 SUBSIDIARIES OF THE REGISTRANT EX-21 1659
9 CONSENT OF CERTIFIED PUBLIC ACCOUNTANTS EX-23 971
10 FINANCIAL DATA SCHEDULE EX-27 2060
  Complete submission text file 0000950144-98-011124.txt   943344
Mailing Address 865 S W 78TH AVENUE PLANTATION FL 33324
Business Address 865 S W 78TH AVENUE TE 100 PLANTATION FL 33324 9542338746
VIRAGEN INC (Filer) CIK: 0000353482 (see all company filings)

EIN.: 592101668 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K405 | Act: 34 | File No.: 000-10252 | Film No.: 98718887
SIC: 2836 Biological Products, (No Diagnostic Substances)